• Nie Znaleziono Wyników

Is performing balloon mitral valvotomy really safe without anticoagulation?

N/A
N/A
Protected

Academic year: 2022

Share "Is performing balloon mitral valvotomy really safe without anticoagulation?"

Copied!
1
0
0

Pełen tekst

(1)

www.kardiologiapolska.pl

List do Redakcji/Letter to the Editor Kardiologia Polska

2011; 69, 8: 879 ISSN 0022–9032

Address for correspondence:

Address for correspondence:

Address for correspondence:

Address for correspondence:

Address for correspondence:

Dr Arunkumar Panneerselvam, MD, DM, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Jaya Nagar 9th Block, BG Road, Bangalore 560069, India, tel: +919 449 821 093, fax: +918 026 534 477, e-mail: drparun1976@gmail.com

Copyright © Polskie Towarzystwo Kardiologiczne

Is performing balloon mitral valvotomy really safe without anticoagulation?

Czy wykonanie balonowej komisurotomii mitralnej bez leczenia przeciwzakrzepowego jest rzeczywiście bezpieczne?

Arunkumar Panneerselvam

Department of Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bangalore, India

I read with interest the article by Ghaffari et al. [1] on performing balloon mitral valvotomy (BMV) with or without anticoagulation. The authors demonstrated the incidence of embolic events to be identical in the two groups.

During BMV, most of the catheter exchanges and ma- nipulations occur at the venous side of the circulatory sys- tem. This, coupled with the low pressures in the venous system, predisposes to thrombus formation. Though the pro- cedure can be done rapidly with minimum exchange by experienced operators in high volume centres, nevertheless it puts the patient at high risk for pulmonary embolism. Re- cently, we had a young patient who developed fatal right

atrial thrombus with pulmonary embolism during BMV de- spite adequate anticoagulation.

It is necessary to use a computed tomography pulmona- ry angiogram to assess the pulmonary circulation for possible thrombus in the group that did not receive heparin. Until then, any recommendation to avoid anticoagulation during BMV can be misleading.

Conflict of interest: none declared References

1. Ghaffari S, Sohrabi B, Aslanabadi N et al. Percutaneous trans- venous mitral commissurotomy: with or without heparin? A ran- domised double blind study. Kardiol Pol, 2011; 69: 445–450.

Cytaty

Powiązane dokumenty

Survival free of mitral valve intervention or heart failure ≥ NYHA III was significantly better for patients with good immediate result and mean pulmonary artery pressure after

In 1969 Fried and MacRae [7] gave an algebraic proof valid for an arbitrary field K under the assumption that ∂f 6≡ 0 mod char K, reducing the theorem to the Jordan–H¨ older

Percutaneous retrograde transfemoral closure of mitral paravalvular leak in 3 patients without con- struction of an arteriovenous wire loop.. Zamorano JL, Badano LP, Bruce C, et

We present a case of a successful re-attempt of PMBV done with the support of a veno-arterial loop after an un- successful mitral valve crossing with an Inoue balloon in the

Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transveneous mitral valvulotomy in patients with

Pacjenta tego wyłączono z leczenia operacyjnego ze względu na duże ryzyko nawrotu skrzepliny, natomiast zwiększono dawki acenokumarolu, uzyskując INR 3,0–3,5.. W

3UG VWDá\]PLHQQ\QDSL FLHVWD &] VWRüRGF]\WX áH]PLHQQHUezystancja, hFE tran- Temperatura pracy zystorów, test diod, akustyczny test 7HPSVNáDGRZDQLD FLJáRFLSRMHPQRüF]

2500 43 Miasto Białystok Przedszkole Samorządowe nr 10 w Białymstoku 3.1.. 3000 44 Miasto Białystok Przedszkole Samorządowe nr 22 w